From FierceBiotech Part of agency’s efforts to promote development of personalized medicines and diagnostics. The U.S. Food and Drug Administration today issued a new draft guidance to facilitate the development and review of companion diagnostics – tests used to help health care professionals determine whether a patient with a particular disease or condition should receive […]